The pharmacovigilance market in the United Kingdom is set to experience significant growth, with a projected compound annual growth rate (CAGR) of 12.1% from 2023 to 2033. This promising outlook highlights the increasing focus on drug safety and efficacy, driven by the rising demand for effective adverse event monitoring and regulatory compliance in the pharmaceutical …